医药行业垄断协议的法律规制研究.pdfVIP

摘要 摘 要 现阶段，我国医药行业存在着严重的垄断行为，尤其是原料药行业，各种垄断行为 频频曝光。垄断协议是一种较为常见的垄断行为，在医药行业时有发生，医药行业对我 国的重要性不言而喻，它不仅是国民经济的重要组成部分，同时又是国民健康的重要保 证，关乎民生大计。目前我国正在对医药行业进行体制改革，随着GPO药品采购模式和 “两票制”的实施，以及政府指导定价的取消，我国医药行业市场化程度加深的同时， 也为垄断协议的发生提供了天然的温床。 理论上我国 《反垄断法》适用于所有的行业，但是在具体行业的适用中也要注重行 业本身的特殊性，而医药行业特殊性则更加突出和明显，对于医药行业的反垄断既要有 力的打击垄断行为，又要注重保障对医药产业的保护和激励，如何平衡二者关系，值得 研究。在明确医药行业的含义及特征基础上，结合当前医药行业针对药品高价采取的两 项政策，即两票制和GPO 药品采购模式，分析我国医药行业垄断协议形成的主要原 因。梳理目前反垄断执法机构披露的医药行业涉及垄断协议的案件，整理出医药行业横 向垄断协议的类型和纵向垄断协议的类型，并结合国外医药行业出现的新型垄断协议， 梳理出了医药行业垄断协议的特征，以此来研究医药行业垄断协议反垄断规制的对策。 关键词 医药行业；垄断协议；豁免制度 - -I 哈尔滨商业大学硕士学位论文 Abstract At present, there are serious monopolistic behaviors in Chinas pharmaceutical industry, especially in theAPI industry.Monopoly agreement isarelatively common monopolybehavior, which occurs frequently in the pharmaceutical industry.The importance of the pharmaceutical industry to our country is self-evident.It isnot only an important part ofthenational economy, but also an important guarantee of national health, which is related to the livelihood of the people.At present, China is carrying out system reform in the pharmaceutical industry. With the implementation of GPO drug purchase mode and two vote system, as well as the cancellation of government guided pricing, the degree of marketization of the pharmaceutical industry in China has deepened, which also provides a natural hotbed for the occurrence of monopoly agreements. Theoretically, Chinas anti-monopoly law is applicable to all industries, but in the application of specific industries, we should also pay attention to the particularity of the industry itself, while the particularity of the pharmaceutical industry is more prominent and obvious.For the anti-monopoly of the pharmaceutical industry,we shou